Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Santarelli

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Biological Psychiatry Global Open Science|January 20, 2025
Pharmacological Enhancement of Adult Hippocampal Neurogenesis Improves Behavioral Pattern Separation in Young and Aged Male MiceWei-Li Chang, Karly Tegang, Benjamin A Samuels, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Pharmacological Enhancement of Adult Hippocampal Neurogenesis Improves Behavioral Pattern Separation in Young and Aged MiceWei-Li Chang, Karly Tegang, Benjamin A Samuels, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2010
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodentsTanya L Wallace, Patrick M Callahan, Ashok Tehim, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 18, 2017
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 ResultsEriene A Youssef, Elizabeth Berry-Kravis, Christian Czech, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)Stephane Nave, Rachelle S Doody, Mercè Boada, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Biological Psychiatry Global Open Science|January 20, 2025
Pharmacological Enhancement of Adult Hippocampal Neurogenesis Improves Behavioral Pattern Separation in Young and Aged Male MiceWei-Li Chang, Karly Tegang, Benjamin A Samuels, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Pharmacological Enhancement of Adult Hippocampal Neurogenesis Improves Behavioral Pattern Separation in Young and Aged MiceWei-Li Chang, Karly Tegang, Benjamin A Samuels, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 21, 2010
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodentsTanya L Wallace, Patrick M Callahan, Ashok Tehim, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 18, 2017
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 ResultsEriene A Youssef, Elizabeth Berry-Kravis, Christian Czech, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)Stephane Nave, Rachelle S Doody, Mercè Boada, et al.
Science (New York, N.Y.)|August 9, 2014
Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophyNikolai A Naryshkin, Marla Weetall, Amal Dakka, et al.
Pageof 5